SLC2A2 and type 2 diabetes mellitus: The first is an intronic variant (transcript NM_000340.2:c.612 + 54T > C) in SLC2A2, which encodes the facilitated glucose transporter GLUT2, and that has been consistently linked to better response to metformin monotherapy in T2DM patients [27,55].